Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H24N2 |
Molar mass | 340.470 g·mol−1 |
3D model (JSmol) | |
| |
|
Acridorex (INN; BS 7573a) is an amphetamine which was investigated as an anorectic but does not appear to have ever been marketed. [1] [2]
An international nonproprietary name (INN) is an official generic and nonproprietary name given to a pharmaceutical drug or an active ingredient. INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. The INN system has been coordinated by the World Health Organization (WHO) since 1953.
Febarbamate, also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate.
Cilofungin (INN) is the first clinically applied member of the echinocandin family of antifungal drugs. It was derived from a fungus in the genus Aspergillus. It accomplishes this by interfering with an invading fungus' ability to synthesize the cell wall.
Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.
Cyclarbamate, also known as cyclopentaphene, is a muscle relaxant and tranquilizer of the carbamate family which has been marketed by Cassenne in France since 1961.
Nisobamate is a tranquilizer of the carbamate family which was never marketed.
Lorbamate is a muscle relaxant and tranquilizer of the carbamate family which was never marketed.
Tetrabarbital is a barbiturate derivative used as a hypnotic.
Lufuradom (INN) is a drug and benzodiazepine derivative which, unlike other benzodiazepines, is described as an analgesic. Similarly to its analogue tifluadom, it was never marketed.
Berefrine, also known as burefrine, is a sympathomimetic and mydriatic agent that was never marketed. It is an oxazolidine prodrug of phenylephrine, and hence, an α1-adrenergic receptor agonist.
Pivenfrine (INN), also known as pivalylphenylephrine, is a sympathomimetic and mydriatic agent.
Morforex, also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.
Picilorex is an anorectic which is no longer marketed. It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.
Oxifentorex (INN) is an amphetamine described as an anorectic which does not appear to have ever been marketed.
Fenisorex is an amphetamine-like anorectic drug which does not appear to have ever been marketed.
Flucetorex (INN) is an amphetamine. It was investigated as an anorectic, but does not appear to have been marketed. It is related to fenfluramine.
Metaglycodol (INN) is a drug described as a tranquilizer which was never marketed.
Aliflurane is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.
Pipoxizine (INN) is a first-generation antihistamine as well as serotonin antagonist of the diphenylmethylpiperazine group related to hydroxyzine. It was investigated as a bronchodilator but was never marketed.
Amelometasone is a synthetic glucocorticoid corticosteroid which was never marketed.